0

539206

GVBL

img img img img
No Data Available

GENOMIC VALLEY BIOTECH LIMITED Share Price Update

As of the latest trading session, GENOMIC VALLEY BIOTECH LIMITED share price is currently at ₹27.45, which is up by ₹1.30 from its previous closing. Today, the stock has fluctuated between ₹26.15 and ₹27.45. Over the past year, GENOMIC VALLEY BIOTECH LIMITED has achieved a return of -52.61%. In the last month alone, the return has been 7.28%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GENOMIC VALLEY BIOTECH LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    8.70

  • P/E Ratio (TTM)

    -189.53

  • Beta

    0.70

  • Book Value / share

    12.85

  • Return on equity

    9.69%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.01

info icon alternate text

GENOMIC VALLEY BIOTECH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.05
Operating Expense 0.04
Net Profit 0.01
Net Profit Margin (%) 20.00
Earnings Per Share (EPS) 0.03
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.09
Operating Expense 0.09
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.09
Operating Expense 0.07
Net Profit 0.02
Net Profit Margin (%) 22.22
Earnings Per Share (EPS) 0.08
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.26
Operating Expense 0.26
Net Profit -0.08
Net Profit Margin (%) -30.76
Earnings Per Share (EPS) -0.27
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.22
Operating Expense 0.07
Net Profit 0.16
Net Profit Margin (%) 72.72
Earnings Per Share (EPS) 0.51
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.84
Operating Expense 0.41
Net Profit 0.36
Net Profit Margin (%) 42.85
Earnings Per Share (EPS) 1.17
EBITDA 0.44
Effective Tax Rate (%) 20.45
Particulars MAR 2024 (Values in Cr)
Revenue 0.17
Operating Expense 0.15
Net Profit 0.02
Net Profit Margin (%) 11.76
Earnings Per Share (EPS) 0.05
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 2.72
Operating Expense 1.85
Net Profit 0.65
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 2.12
EBITDA 0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.07
Operating Expense 0.57
Net Profit -0.01
Net Profit Margin (%) -14.28
Earnings Per Share (EPS) -0.03
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.21
Operating Expense 0.72
Net Profit -0.56
Net Profit Margin (%) -266.66
Earnings Per Share (EPS) -1.83
EBITDA -0.13
Effective Tax Rate (%) -12.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.76
ROE % 9.69
ROCE % 12.11
Total Debt to Total Equity 0.00
EBITDA Margin 52.38
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 0.57
ROCE % 0.57
Total Debt to Total Equity 0.00
EBITDA Margin 11.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.55
ROE % 28.48
ROCE % 25.67
Total Debt to Total Equity 0.00
EBITDA Margin 33.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin -428.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.69
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.32
EBITDA Margin -61.90
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.35
Total Liabilities 4.35
Total Equity 3.89
Share Outstanding 0
Price to Book Ratio 4.59
Return on Assets (%) 8.17
Return on Capital (%) 9.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 4.33
Total Liabilities 4.33
Total Equity 3.54
Share Outstanding 0
Price to Book Ratio 2.99
Return on Assets (%) 0.35
Return on Capital (%) 0.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.42
Total Liabilities 4.42
Total Equity 3.52
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.66
Return on Capital (%) 18.38
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.79
Total Liabilities 3.79
Total Equity 2.87
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.24
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.61
Total Liabilities 7.61
Total Equity 4.48
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -7.33
Return on Capital (%) -9.26
Particulars MAR 2025 (Values in Cr)
Net Income 0.44
Cash from Operations 0.11
Cash from Investing 0.01
Cash from Financing 0.00
Net change in Cash 0.03
Free Cash Flow 0.12
Particulars MAR 2024 (Values in Cr)
Net Income 0.01
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow -0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.91
Cash from Operations -0.77
Cash from Investing 1.52
Cash from Financing -0.70
Net change in Cash 0.03
Free Cash Flow -0.77
Particulars MAR 2022 (Values in Cr)
Net Income -0.42
Cash from Operations -2.12
Cash from Investing 3.66
Cash from Financing -1.54
Net change in Cash 0.00
Free Cash Flow -2.12
Particulars MAR 2021 (Values in Cr)
Net Income -0.50
Cash from Operations 1.48
Cash from Investing -1.57
Cash from Financing 0.06
Net change in Cash -0.02
Free Cash Flow 3.06
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
KESORAM INDUSTRIES LTD 7.51 0.00 0.67 233.34 2.94 14.25
Max Financial Services Limited 1644.90 393.52 10.70 56767.93 1032.90 1891.35
MODI RUBBER LTD 114.00 18.18 0.52 285.46 87.25 167.80
THOMAS COOK (INDIA) LTD 87.95 16.35 2.33 4137.00 86.50 188.45
RAIN INDUSTRIES LIMITED 112.70 89.44 0.50 3790.66 99.85 175.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
FGP LTD. 8.55 50.29 2.77 10.17 7.32 13.70
KESORAM INDUSTRIES LTD 7.51 23.47 0.71 233.34 2.94 14.25
MPIL CORPORATION LTD. 351.50 0.00 1.56 20.04 324.70 787.35
Max Financial Services Limited 1644.90 0.00 8.42 56767.93 1032.90 1891.35

GENOMIC VALLEY BIOTECH LIMITED shareholding pattern

Holding

53.93%
46.06%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GENOMIC VALLEY BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
28.43 0.00 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 26.50
  • 26 Days 26.20
  • 10 Days 26.40
  • 50 Days 26.20
  • 12 Days 26.40
  • 100 Days 28.50
  • 20 Days 26.30
  • 200 Days 34.60
28.93 PIVOT

First Support

27.93

First Resistance

29.44

Second Support

27.42

Second Resistance

30.44

Third Support

26.42

Third Resistance

30.95

RSI

59.60

ADX

34.68

MACD

0.20

Williams % R

-16.13

Commodity Channel Index (CCI)

129.65

Date

2026-03-16

Week

293.00

Same Day

623.00

Month

595.00

1 Year

0.70

3 Year

0.42

Over 1 Month

7.28%

down

Over 1 Year

-52.61%

down

Over 3 Months

18.45%

down

Over 3 Years

11.15%

down

Over 6 Months

-25.16%

down

Over 5 Years

4.78%

down

GENOMIC VALLEY BIOTECH LIMITED Corporate Actions

Top Gainers

GENOMIC VALLEY BIOTECH LIMITED Share Price

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The Company is extensively involved in commercial greenhouse / poly house cultivation of crops. Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

The Company identified a cluster of 700 marginal farmers eligible to form a Farmers Producer Company. It already started opening a training centre, imparting training to farmers and agri-entrepreneurs profitably. Separate courses have been designed for Training like the Ladies to develop kitchen gardens or small farms which can fetch them profits by growing fruits and vegetables. Apart from this, the Company is also providing Agri Farming Consultancy to farmers and other clients on case to case basis.

In 2025, Company launched and optimized a dynamic website to serve as a hub for its services and values. It expanded the services to include advanced genomic pipelines like Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis, and Targeted Sequencing Panels. It started two groundbreaking projects: one exploring the genetic basis of Chronic Kidney Disease (CKD) and another combining genomics with Ayurveda in a Hair Follicle Growth Study. By building a comprehensive database and conducting in-depth market research, Company enhanced the understanding of healthcare trends, delivering solutions to the needs of patients and clinicians effectively.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Genomic Valley Biotech Ltd?

Answer Field

Genomic Valley Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 28.43 as on Apr 10 2026 03:15 PM.

What is the Market Cap of Genomic Valley Biotech Ltd Share?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 8.70 as on Apr 10 2026 03:15 PM.

What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

Answer Field

The 52 Week High and Low of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 70.89 and ₹ 20.10.

What is 1 year return for Genomic Valley Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -52.61%.

What is the P/E Ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Apr 10 2026 03:15 PM the price-to-earnings (PE) ratio for Genomic Valley Biotech Ltd share is -189.53.

What is the PB ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Apr 10 2026 03:15 PM, the price-to-book (PB) ratio for Genomic Valley Biotech Ltd share is 12.85.

How to Buy Genomic Valley Biotech Ltd Share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genomic Valley Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Genomic Valley Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genomic Valley Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59